Table 1.
Demographic data.
| Study population (n = 77) | n | % | ||
|---|---|---|---|---|
| Males | 55 | 71.4 | ||
| Females | 22 | 28.6 | ||
| Age (years) | 63.7 ± 11.7 | |||
| Body mass index (BMI—kg/m²) | 28.9 ± 5.7 | |||
| Comorbidities | n | % | ||
| Ischemic Cardiomyopathy | 37 | 48.1 | ||
| Non-ischemic Cardiomyopathy | 40 | 51.9 | ||
| Atrial Fibrillation | 30 | 39 | ||
| Paroxysmal | 7 | 9.1 | ||
| Persistent | 14 | 18.2 | ||
| Permanent | 9 | 11.7 | ||
| Coronary Heart Disease | 47 | 61.4 | ||
| Chronic obstructive pulmonary disease | 15 | 19.5 | ||
| Diabetes mellitus | 22 | 28.6 | ||
| Arterial hypertension | 57 | 74 | ||
| Overweight (BMI >25 kg/m²) | 53 | 68.8 | ||
| Arrhythmic events and Outcome | n | % | ||
| Non sustained ventricular tachycardia | 4 | 5.2 | ||
| Sustained ventricular tachycardia | 0 | 0 | ||
| Ventricular fibrillation | 0 | 0 | ||
| ICD Implantation | 18 | 23.4 | ||
| CRT-D Implantation | 9 | 11.7 | ||
| No device implantation | 50 | 64.9 | ||
| Improvement of LVEF >35% | 44 | 57,1 | ||
LVEF, left ventricular ejection fraction; ICD, implantable cardioverter defibrillator; CRT-D, cardiac resynchronization therapy defibrillator.